Publications by authors named "Victoria Raymond"

Claim this Profile
C
Colonoscopic Follow-Up After Abnormal Blood-Based Colorectal Cancer Screening Results.
Timothy A Zaki, Nicole J Zhang, Shaun P Forbes, Victoria M Raymond, Amar K Das

Gastroenterology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of blood-based colorectal cancer screening: real-world adherence and outcomes.
Candice Graham-Adderton, Carmen E Guerra, Quyen Ngo-Metzger, Theresa Hoang, Victoria M Raymond

Curr Med Res Opin· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of blood-based colorectal cancer screening - a simulation model incorporating real-world longitudinal adherence.
Elifnur Yay Donderici, Shaun P Forbes, Nicole J Zhang, Gregory Schafer, Victoria M Raymond

Expert Rev Pharmacoecon Outcomes Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating Complexity: Perspectives on Risk Assessment in the Era of New Blood-Based Tests for Early Cancer Detection.
Christina A Clarke, Breeana L Mitchell, Emma Alme, Jonathan P Beer, Tomasz M Beer, Victoria M Raymond

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lexicon for blood-based early detection and screening: BLOODPAC consensus document.
Christina A Clarke, Breeana L Mitchell, Girish Putcha, Emma Alme, Peter Bach, Victoria M Raymond

Clin Transl Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population health outcomes of blood-based screening for colorectal cancer in comparison to current screening modalities: insights from a discrete-event simulation model incorporating longitudinal adherence.
Shaun P Forbes, Elifnur Yay Donderici, Nicole Zhang, Behnam Sharif, Gabriel Tremblay, Victoria M Raymond

J Med Econ· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment.
Aparna R Parikh, Bryant H Chee, Jill Tsai, Thereasa A Rich, Kristin S Price, Victoria M Raymond

Clin Cancer Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stool and Blood DNA Tests for Colorectal Cancer Screening. Reply.
Daniel C Chung, Victoria M Raymond, William M Grady

N Engl J Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.
Daniel C Chung, Darrell M Gray, Harminder Singh, Rachel B Issaka, Victoria M Raymond

N Engl J Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(HER2) amplifications and co-occurring alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition.
Afsaneh Barzi, Caroline M Weipert, Carin R Espenschied, Victoria M Raymond, Andrea Wang-Gillam

Front Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver Metastases.
Timothy E Newhook, Michael J Overman, Yun Shin Chun, Arvind Dasari, Ching-Wei D Tzeng, Victoria Raymond

Ann Surg· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Landscape and Clonal Dominance of Co-occurring Genomic Alterations in Non-Small-Cell Lung Cancer Harboring Exon 14 Skipping.
Xiuning Le, Lingzhi Hong, Chuck Hensel, Rongrong Chen, Haley Kemp, Victoria Raymond

JCO Precis Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With -Mutated Cholangiocarcinoma Treated With Isocitrate Dehydrogenase Inhibitors.
Morten Lapin, Helen J Huang, Sharmeen Chagani, Milind Javle, Rachna T Shroff, Victoria M Raymond

JCO Precis Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer.
Ray D Page, Leylah M Drusbosky, Hiba Dada, Victoria M Raymond, Davey B Daniel

Clin Lung Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878).
Jonathan W Riess, Karen L Reckamp, Paul Frankel, Jeffrey Longmate, Karen A Kelly, Victoria M Raymond

Clin Lung Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer.
Aparna R Parikh, Emily E Van Seventer, Giulia Siravegna, Anna V Hartwig, Ariel Jaimovich, Victoria M Raymond

Clin Cancer Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based classification predicts drug response in EGFR-mutant NSCLC.
Jacqulyne P Robichaux, Xiuning Le, R S K Vijayan, J Kevin Hicks, Simon Heeke, Victoria Raymond

Nature· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Functional Characterization of Atypical / Mutations in Metastatic Colorectal Cancer.
Jonathan M Loree, Yucai Wang, Muddassir A Syed, Alexey V Sorokin, Oluwadara Coker, Victoria M Raymond

Clin Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial.
Joana Vidal, David Casadevall, Beatriz Bellosillo, Carles Pericay, Rocio Garcia-Carbonero, Victoria Raymond

Clin Cancer Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC.
Vincent K Lam, Jianjun Zhang, Carol C Wu, Hai T Tran, Lerong Li, Victoria M Raymond

J Thorac Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of Targeted Therapy in Patients With Advanced Non-small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis.
Karen L Reckamp, Tejas Patil, Kedar Kirtane, Thereasa A Rich, Carin R Espenschied, Victoria M Raymond

Clin Lung Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Landscape of BRAF-Mutant NSCLC Reveals an Association Between Clonality and Driver Mutations and Identifies Targetable Non-V600 Driver Mutations.
Marcelo V Negrao, Victoria M Raymond, Richard B Lanman, Jacqulyne P Robichaux, Junqin He

J Thorac Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA Assay.
Katherine Clifton, Thereasa A Rich, Christine Parseghian, Victoria M Raymond, Arvind Dasari

JCO Precis Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Actionable Genomic Alterations Using Circulating Cell-Free DNA.
Nora S Sánchez, Michael P Kahle, Ann Marie Bailey, Chetna Wathoo, Kavitha Balaji, Victoria M Raymond

JCO Precis Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal Cancer.
Benny Johnson, Jonathan M Loree, Alexandre A Jacome, Shehara Mendis, Muddassir Syed, Victoria M Raymond

JCO Precis Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis